Ronald Levy

13PUBLICATIONS
37CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 10, 2025
Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging.

Nisi Zhang, Jai Woong Seo, Elise Robinson

|Jan 02, 2025
A Phase I Clinical Trial Adding OX40 Agonism to In Situ Therapeutic Cancer Vaccination in Patients with Low-Grade B-cell Lymphoma Highlights Challenges in Translation from Mouse to Human Studies.

Tanaya Shree, Debra Czerwinski, Sarah Haebe

|Jun 20, 2023
The molecular mechanism of CD81 antibody inhibition of metastasis.

Niroz Abu-Saleh, Chiung-Chi Kuo, Wei Jiang

|May 31, 2023
Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors.

Caitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer

|May 27, 2022
Intratumoral immunotherapy relies on B and T cell collaboration.

Idit Sagiv-Barfi, Debra K Czerwinski, Tanaya Shree

|Feb 09, 2022
Neoadjuvant Intratumoral Immunotherapy with TLR9 Activation and Anti-OX40 Antibody Eradicates Metastatic Cancer.

Wan Xing Hong, Idit Sagiv-Barfi, Debra K Czerwinski

Pageof 3

Frequent Collaborators

4 joint publications

Idit Sagiv-Barfi

4 joint publications

Tanaya Shree

3 joint publications

Shoshana Levy

2 joint publications

Adrienne Sallets